Vyome Therapeutics

Developer of therapeutics for the immuno-inflammatory conditions

placePrinceton, New Jersey, United States calendar_todayFounded 2010 groups8 employees language vyometx.com

Registered entities

Innovation

13 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 294 times.

YearFilings
20161
20174
20181
20197
20204
20216
20222
20231
20251
20261

Social engagement

Social engagement: 5.1K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Navam Capital, Iron Pillar, Perceptive Advisors, Romulus Capital; 2 have since exited.

Investor typeCountShare
Venture capital1077%
Private equity18%
Angel & family office18%
Other / undisclosed18%
Coming soon